Clinical Trial Update: A Study of Ocrelizumab Compared to Placebo in Patients With Active Rheumatoid Arthritis Who Don't Have a Response to Anti-TNF-α Therapy (SCRIPT) [Phase 3]

View source ↗

Summary

A Phase 3 trial of ocrelizumab vs placebo in active rheumatoid arthritis patients non-responsive to anti-TNF-α therapy was terminated; results were posted in 20…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• Ocrelizumab (ocrelizumab)

Snippet

Sponsor: Genentech, Inc. | Conditions: Rheumatoid Arthritis | Phase 3 | Status: TERMINATED | Results posted: 2019-08-12